Globe Life stock analysis
Globe Life (0ADQ) Share Price & Analysis
0ADQ Stock Chart & Stats
- Day’s Range
- $122.55 - $122.55
- 52-Week Range
- $122.55 - $122.55
- Previous Close
- $122.55
- Volume
- N/A
- Average Volume (3M)
- 0
- Market Cap
- $12.33B
- Enterprise Value
- $15.94B
- Total Cash (Recent Filing)
- $17.23B
- Total Debt (Recent Filing)
- $2.99B
- Price to Earnings (P/E)
- 10.6
- Beta
- 1.15
- Next Earnings
- Feb 10, 2027 (Est.)
- EPS Estimate
- 3.64
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 0.76%
Bulls Say, Bears Say
Bulls Say
Premium Growth
Broad premium growth supports recurring revenue and demonstrates demand across both life and health products. The strong health trajectory and continued life expansion diversify growth drivers, while management’s 2027 outlook suggests the momentum is expected to persist beyond one reporting period.
Cash Generation
Robust conversion of earnings into operating and free cash flow gives Globe Life substantial internal funding capacity. This supports policyholder obligations, investment in distribution and technology, and shareholder returns without depending as heavily on external financing.
Capital And Investment Quality
A predominantly investment-grade portfolio and strong regulatory capital position reinforce financial resilience for an insurer. These buffers improve the company’s ability to absorb claims or market volatility, maintain confidence in its obligations, and preserve flexibility for growth and capital allocation.
Bears Say
Margin Pressure
Lower health margins and weaker trailing profitability indicate that revenue growth is not translating into earnings at the prior level of efficiency. If margin pressure persists, it could constrain earnings growth, reduce cash available for capital returns, and make future guidance more difficult to achieve.
Distribution Execution
Weakness in agent recruitment and direct-to-consumer acquisition affects the channels that generate new policy sales and future premium growth. Compensation changes and digital advertising adaptations may help, but execution risk remains as Globe Life works to rebuild agent capacity and stabilize customer acquisition.
Evri Underwriting Volatility
Evri’s limited scale and unusually severe claims create a continuing source of underwriting volatility within the health business. Losses that persist into 2027 could dilute otherwise favorable portfolio results, pressure consolidated margins, and require more time or capital before the operation reaches credible profitability.
Globe Life News
0ADQ FAQ
What was Globe Life’s price range in the past 12 months?
What is Globe Life’s market cap?
When is Globe Life’s upcoming earnings report date?
How were Globe Life’s earnings last quarter?
Is Globe Life overvalued?
Does Globe Life pay dividends?
What is Globe Life’s EPS estimate?
How many shares outstanding does Globe Life have?
What happened to Globe Life’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Globe Life?
What is the TipRanks Smart Score and how is it calculated?
Globe Life Stock Smart Score
Company Description
Globe Life
Globe Life Inc. delivers diverse life insurance and supplementary health coverage, alongside annuity products, targeting households in the lower-middle to middle-income brackets throughout the United States. The company's operations are structured into four key segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. Its offerings encompass whole life, term life, and other life protection plans; supplemental health benefits like Medicare supplements, critical illness, and accident policies; and both single-premium and flexible-premium deferred annuities. Founded in 1979 and headquartered in McKinney, Texas, the enterprise rebranded from Torchmark Corporation to Globe Life Inc. in August 2019.
- Sector
- Financial
- Industry
- Insurance - Life
- CEO
- Frank Martin Svoboda
- Employees
- 3,695
- Website
- home.globelifeinsurance.com
- Address
- 7677 Henneman Way, McKinney, TX, 75070, US
Globe Life (0ADQ) Earnings & Revenues
0ADQ Earnings Call
Earnings Call SentimentPositive
The call was broadly constructive. Management reported growth in operating income, total and health premiums, book value, sales activity, investment income, capital flexibility, and shareholder returns, while also outlining favorable claims experience, AI initiatives, Bermuda-related cash flow opportunities, and 2027 growth guidance. These positives were partially offset by a 2% decline in GAAP net income, lower 2026 EPS guidance, direct-to-consumer and American Income recruiting challenges, lower life and health margin metrics, CMS-related claims disruption, and significant volatility and losses at the early-stage Evri business.
View all GB:0ADQ earnings summaries0ADQ Net sales Breakdown
- 56.44% Life
- 24.31% Health
- 0.00% Annuity
- 19.65% Investment
- <0.01% Corporate & Other
- -0.42% Realized gains (losses)
0ADQ Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 7 | 5 | 2 |
| Technical Analysis | 1 | 1 | 0 |
| Moving Averages | 6 | 4 | 2 |












